We are live on
!
Find out more
B
Bailard Portfolio holdings
AUM
$4.35B
1-Year Est. Return
23.57%
This Fund
S&P 500
This Quarter
Est. Return
+21.05%
1 Year Est. Return
+23.57%
3 Year Est. Return
+74.84%
5 Year Est. Return
+96.64%
10 Year Est. Return
+374.16%
AUM
$1.79B
AUM Growth
+$386M
(+27%)
Cap. Flow
+$121M
Cap. Flow
% of AUM
6.74%
Top 10 Holdings %
Top 10 Hldgs %
33.84%
Holding
575
New
129
Increased
174
Reduced
152
Closed
75
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$47.2M |
| 2 |
iShares Core MSCI EAFE ETF
IEFA
|
+$39.6M |
| 3 |
iShares National Muni Bond ETF
MUB
|
+$10.5M |
| 4 |
L3Harris
LHX
|
+$4.57M |
| 5 |
Vanguard Small-Cap Value ETF
VBR
|
+$4.18M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares S&P Small-Cap 600 Value ETF
IJS
|
+$5.36M |
| 2 |
State Street SPDR Nuveen ICE Municipal Bond ETF
TFI
|
+$4.62M |
| 3 |
Gilead Sciences
GILD
|
+$4.55M |
| 4 |
Vanguard Total Stock Market ETF
VTI
|
+$4.16M |
| 5 |
Meta Platforms (Facebook)
META
|
+$4.11M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.8% |
| 2 | Healthcare | 8.12% |
| 3 | Financials | 4.94% |
| 4 | Communication Services | 4.63% |
| 5 | Consumer Discretionary | 4.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Sanofi
SNY
$104B
| $598K | 0.03% |
11,717
+1,188
| +11% | +$57.7K |
|
252
Vanguard Small-Cap ETF
VB
$79.7B
| $597K | 0.03% |
4,100
-1,377
| -25% | -$185K |
|
253
Vanguard Materials ETF
VAW
$3B
| $596K | 0.03% |
4,938
-1,327
| -21% | -$149K |
|
254
Applied Materials
AMAT
$434B
| $592K | 0.03% |
9,797
-257
| -3% | -$13.9K |
|
255
Enbridge
ENB
$124B
| $588K | 0.03% |
19,339
+899
| +5% | +$27.6K |
|
|
AIV
256
Aimco
AIV
$381M
| $568K | 0.03% |
+113,353
| New | +$562K |
|
257
Air Products & Chemicals
APD
$66B
| $564K | 0.03% |
2,334
+72
| +3% | +$16.4K |
|
|
APLS
258
DELISTED
Apellis Pharmaceuticals
APLS
| $552K | 0.03% |
16,900
+5,000
| +42% | +$161K |
|
259
RTX Corp
RTX
$287B
| $549K | 0.03% |
8,903
-7,669
| -46% | -$479K |
|
260
State Street SPDR S&P 600 Small Cap Value ETF
SLYV
$4.91B
| $545K | 0.03% |
11,092
-629
| -5% | -$28.8K |
|
|
FBC
261
DELISTED
Flagstar Bancorp, Inc. New
FBC
| $542K | 0.03% |
18,400
+4,900
| +36% | +$126K |
|
262
Associated Banc-Corp
ASB
$5.86B
| $536K | 0.03% |
+39,200
| New | +$533K |
|
|
KYNB
263
Kyntra Bio
KYNB
$28.6M
| $533K | 0.03% |
526
| – | – |
|
264
Alexandria Real Estate Equities
ARE
$8.88B
| $530K | 0.03% |
3,265
+105
| +3% | +$16K |
|
265
iShares Biotechnology ETF
IBB
$9.35B
| $530K | 0.03% |
3,880
| – | – |
|
266
COPT Defense Properties
CDP
$4.31B
| $527K | 0.03% |
20,800
+9,500
| +84% | +$237K |
|
267
Alnylam Pharmaceuticals
ALNY
$36.4B
| $518K | 0.03% |
3,500
| – | – |
|
268
The Bancorp
TBBK
$2.79B
| $510K | 0.03% |
52,000
+6,100
| +13% | +$45.9K |
|
269
Becton Dickinson
BDX
$42.9B
| $506K | 0.03% |
2,169
-786
| -27% | -$189K |
|
270
Iovance Biotherapeutics
IOVA
$2.25B
| $505K | 0.03% |
18,400
-48,200
| -72% | -$1.58M |
|
271
BioMarin Pharmaceuticals
BMRN
$11.4B
| $493K | 0.03% |
4,000
| – | – |
|
272
Fresenius Medical Care
FMS
$13.2B
| $490K | 0.03% |
11,320
+422
| +4% | +$16.7K |
|
|
RC
273
Ready Capital
RC
$270M
| $484K | 0.03% |
55,746
+2,607
| +5% | +$17.7K |
|
274
Biogen
BIIB
$29.9B
| $478K | 0.03% |
1,788
+27
| +2% | +$8.12K |
|
275
Digital Realty Trust
DLR
$75.3B
| $478K | 0.03% |
3,367
| – | – |
|
Similar funds
EC
SFM
NHC
EQF
NEI
MYIA
Bailard's Q2 2020 Portfolio in Review
As of Q2 2020, Bailard held 575 positions worth $1.79B, up 27% from $1.4B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Bailard deployed $121M of net new capital in Q2 2020, opening 129 new positions and adding to 174 existing holdings. Its largest new stake was L3Harris: 24,296 shares worth $4.12M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was iShares S&P Small-Cap 600 Value ETF, an estimated $5.36M trimmed.
- Bailard's largest Q2 2020 buy was L3Harris: 24,296 shares worth $4.12M.
- Bailard added most to State Street SPDR S&P 500 ETF Trust in Q2 2020, an estimated $47.2M increase.
- Bailard's biggest Q2 2020 reduction was iShares S&P Small-Cap 600 Value ETF, cutting an estimated $5.36M.
- Bailard fully exited Voyager Therapeutics in Q2 2020, selling an estimated $1.29M.
- Bailard's ten largest holdings make up 34% of its $1.79B portfolio in Q2 2020.
- Bailard opened 129 new positions and closed 75 in Q2 2020.
- Bailard's portfolio value rose 27% quarter-over-quarter to $1.79B.
Based on Bailard's 13F filing for Q2 2020, filed 12 Aug 2020.